Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD4-Specific T-cell Vaccine in HIV Infection
NCT00407836Phase 2Completed
- Sponsor
- Soroka University Medical Center
- Start
- Nov 2006
- Primary completion
- Nov 2008
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of CD4-specific T-cell vaccine in human immunodeficiency virus infection (HIV), sponsored by Soroka University Medical Center. Started Nov 2006; status: completed.
02
Drugs
CD4-specific T-cell vaccine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00407836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407836.